Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR-2: Iloprost Inhalation in Pulmonary Hypertension
NCT00414687Phase 2Completed
- Sponsor
- Bayer
- Start
- Jul 1998
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, open-label trial in pulmonary hypertension (PH) comparing Iloprost Inhalation with Standard of Care (2 arms). Primary endpoints: Adverse events (AE) and safety variables, Variables to describe clinical effects and 2 more. Started Jul 1998; status: completed.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00414687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414687.